Lisa O’Brien looked at her heart monitor in disbelief. During the past several weeks, she’d had erratic heart rates that varied tremendously from 30 beats per minute (bpm) to the dangerously high number that she stared at now: 220 bpm.

At this point in the COVID-19 pandemic, regardless of which combination of vaccinated, boosted, and/or naturally infected we claim, all of us who have developed antibodies against SARS-CoV-2 have the same questions: Are we immune to infection, and if so, how long will that immunity last?

In the early days of the COVID-19 pandemic, employees at ARUP Laboratories and the University of Utah were first responders to the emerging crisis as they raced to validate tests and build much-needed testing capacity.

Alessandro Rossi, PhD, D(ABMM), chief scientist of Infectious Disease and CLIA director at the Utah Public Health Laboratory, was a microbiology fellow at ARUP Laboratories from 2015 to 2017. Over the course of his career, his work and research projects have advanced the field of clinical microbiology and guided public health interventions.

ARUP’s Institute for Learning (IFL) team works hard every day to create, refine, and publish quality, no-cost training materials for medical laboratory scientists (MLSs) and physicians. Each year, the IFL produces four live webinars, publishes an average of 35 CME and 40 P.A.C.E.^® courses, creates 14 LabMind podcast episodes, and hosts a weeklong anatomic pathology medical conference in Park City, Utah. Here, we highlight the IFL’s growth and achievements in recent years.